Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell–killing capability
Eliana Ribechini, Ina Eckert, Andreas Beilhack, Nelita Du Plessis, Gerhard Walzl, Ulrike Schleicher, Uwe Ritter, Manfred B. Lutz
Eliana Ribechini, Ina Eckert, Andreas Beilhack, Nelita Du Plessis, Gerhard Walzl, Ulrike Schleicher, Uwe Ritter, Manfred B. Lutz
View: Text | PDF
Research Article Immunology Infectious disease

Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell–killing capability

  • Text
  • PDF
Abstract

Tuberculosis patients and mice infected with live Mycobacterium tuberculosis accumulate high numbers of myeloid-derived suppressor cells (MDSCs). Here, we hypothesized that dead M. tuberculosis vaccines also may induce MDSCs that could impair the efficacy of vaccination. We found that repeated injections of M. tuberculosis vaccines (heat-killed M. tuberculosis in incomplete Freund’s adjuvant, such as Montanide) but not single or control vaccines without M. tuberculosis strongly expanded CD11b+ myeloid cells in the spleen, leading to T cell suppression of proliferation and killing ex vivo. Dead M. tuberculosis vaccination induced the generation of CD11b+Ly6ChiCD115+ iNOS/Nos2+ monocytic MDSCs (M-MDSCs) upon application of inflammatory or microbial activation signals. In vivo these M-MDSCs were positioned strategically in the splenic bridging channels and then positioned in the white pulp areas. Notably, within 6–24 hours, in a Nos2-dependent fashion, they produced NO to rapidly kill conventional and plasmacytoid DCs while, surprisingly, sparing T cells in vivo. Thus, we demonstrate that M. tuberculosis vaccine induced M-MDSCs do not directly suppress effector T cells in vivo but, instead, indirectly by killing DCs. Collectively, we demonstrate that M. tuberculosis booster vaccines induce M-MDSCs in the spleen that can be activated to kill DCs. Our data suggest that formation of MDSCs by M. tuberculosis vaccines should be investigated also in clinical trials.

Authors

Eliana Ribechini, Ina Eckert, Andreas Beilhack, Nelita Du Plessis, Gerhard Walzl, Ulrike Schleicher, Uwe Ritter, Manfred B. Lutz

×

Figure 5

MDSC-mediated DC killing is iNOS dependent.

Options: View larger image (or click on image) Download as PowerPoint
MDSC-mediated DC killing is iNOS dependent.
(A) C57BL/6 WT mice (n = 3) ...
(A) C57BL/6 WT mice (n = 3) were immunized s.c. with CFA/CFA or were left untreated (without CFA) and challenged with LPS/IFN-γ, M. tuberculosis/IFN-γ, or vehicle (0h). Spleens were harvested after 6 hours, 24 hours, and 48 hours after the mice received the challenge injections, and the absolute cDC, pDC, and CD4+ and CD8+ T cell numbers were calculated from the frequencies of the indicated surface marker stainings among the whole spleen cell counts. (B) C57BL/6 WT (n = 3) and Nos2–/– mice (n = 3) were used for immunization as above but only challenged with LPS/IFN-γ. The individual cell populations were stained using the indicated markers and analyzed by flow cytometry after 6 hours and 24 hours for the frequency of apoptotic cells using annexin V or (C) their live-cell frequencies were calculated. (D) DC in vitro killing assay. In vitro–generated BM-DCs were matured overnight with LPS and then cocultured at 1:1 ratio with M. tuberculosis–activated BM-MDSCs that were generated from WT or Nos2–/– mice and sorted into CD11b+Ly6ChiLy 6G– monocytic or CD11b+Ly6CloLy6G+ granulocytic cell subsets (n = 4 independent experiments). Apoptosis of DCs was determined by annexin V FACS staining and normalized to DC cultures without BM-MDSCs. (E) Cryosections of spleens from CFA/CFA plus LPS/IFN-γ–immunized mice were analyzed by confocal microscopy to assess apoptosis of CD11c+ DCs via TUNEL or FVF staining. B cell areas were identified by B220 staining. Scale bars: 60 μm. (F) Quantification of E at 24 hours. CD11c+TUNEL+ cells within the T cell zone of WT (n = 16) and Nos2–/– (n = 20) spleen cryosections were analyzed with StrataQuest software. (G) Cytospin preparations of LPS-matured BM-DC and M. tuberculosis–activated BM-MDSC cocultures to demonstrate CD11c+TUNEL+ DC killing in vitro. Statistics shown in black were performed using an unpaired 2-tailed t test. *P < 0.05, **P < 0.01, ***P < 0.001. Mean and SD are shown. Statistical P values shown in red were performed using 2-way ANOVA testing for changes over time, while no differences were found between the differentially treated groups. Statistical P values shown in blue were performed using 2-way ANOVA testing for changes over time and between the WT and Nos2–/– mice. ANOVA analyses were performed without the group that received only LPS/IFN-γ (violet bars).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts